HEPATITIS C
TREATMENTS |
|
|
Some patients with hepatitis C benefit
from treatment with interferon alpha or a combination of interferon
alpha and ribavirin.
Interferon alpha is given by injection just under the skin and has a
number of side effects, including flu-like symptoms, headaches,
fever, fatigue, loss of appetite, nausea, vomiting, depression, and
thinning of hair. Treatment with interferon alpha may also interfere
with the production of white blood cells and platelets.
Ribavirin is a capsule taken twice daily, and the major side effects
are severe anemia (low red blood cells) and birth defects. Women
should therefore avoid pregnancy during and for 6 months following
treatment.
Recently, a version of interferon alpha with a longer half-life (pegylated
interferon alpha) was introduced, and the longer half-life means the
injections are taken weekly instead of the three times a week with
standard interferon alpha. Pegylated interferon alpha and ribavirin
lead to a sustained response in approximately 50% of patients.
A sustained response means that the patient remains free of
hepatitis C virus 6 months after stopping therapy. Approximately 40%
of patients with genotype 1 infection will respond.
Rest may be recommended during the acute phase of the disease when
the symptoms are most severe. People with hepatitis C should avoid
any substances toxic to the liver (hepatotoxic). All patients with
hepatitis C should be immunized against hepatitis A and B.
People with hepatitis C should also be careful not to take vitamins,
nutritional supplements, or new over-the-counter medications without
first discussing it with their doctor. Patients with hepatitis C
should avoid alcohol. Even moderate amounts of alcohol speed up the
progression of hepatitis C, and alcohol reduces the effectiveness of
the treatment. |
|
|
| HEPATITIS C RELATED ITEMS |
|
|
|
|